Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
KSHV Inflammatory Cytokine Syndrome (KICS): early-phase trial registry
2 of 2 indexed KSHV Inflammatory Cytokine Syndrome (KICS) trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #7,188 of 28,707 conditions by registered trial count.
2 US clinical trials · 2 currently recruiting · #7,188 of 28,707 conditions by registered trial count
KSHV Inflammatory Cytokine Syndrome (KICS): 2 US clinical trials tracked, 2 recruiting.
KSHV Inflammatory Cytokine Syndrome (KICS) is the subject of 2 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is National Cancer Institute (NCI), running 2 of these trials.
Enrollment posture brief
Registry condition kshv-inflammatory-cytokine-syndrome-kics
OPEN 2 | RECR 100% | LATE 0 | EARLY 2 | RANK #7188 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)
KSHV Inflammatory Cytokine Syndrome (KICS) lists 2 open slots (100% of 2 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for KSHV Inflammatory Cytokine Syndrome (KICS) on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
KSHV Inflammatory Cytokine Syndrome (KICS) is recruiting above its size-band peers.
2 of 2 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
2 total, page 1 of 1
Natural History Study of the KSHV Inflammatory Cytokine Syndrome (KICS)
National Cancer Institute (NCI)
NCT01419561
Phase II Study of Pacritinib in Kaposi Sarcoma Herpesvirus (KSHV)-Associated Multicentric Castleman Disease and KSHV-Associated Inflammatory Cytokine Syndrome (KICS)
National Cancer Institute (NCI)
NCT06052618
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on KSHV Inflammatory Cytokine Syndrome (KICS) records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on KSHV Inflammatory Cytokine Syndrome (KICS) trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this KSHV Inflammatory Cytokine Syndrome (KICS) page
2 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 KSHV Inflammatory Cytokine Syndrome (KICS) trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- National Cancer Institute (NCI) sponsors the most KSHV Inflammatory Cytokine Syndrome (KICS) trials on record, review their full trial history before evaluating a specific study. See National Cancer Institute (NCI)'s trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This KSHV Inflammatory Cytokine Syndrome (KICS) condition card totals 2 registered trials; most-linked intervention Standard Therapies; top US site state Maryland. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.